Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-30

Clinical Trial Update: The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates the effects of early vs. late injection of Botulinum Toxin Type A on upper limb function in stroke patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Stroke | Phase 3 | Status: UNKNOWN